|
REFERENCES
[1] Josse R, Guédénon A, Darie H, Anagonou S, Portaels F, Meyers WM: Les infections cutanées à Mycobacterium ulcerans: Ulcères de Buruli. Med Trop 1995, 55: 363-373. [1] Josse R, Guédénon A, Darie H, Anagonou S, Portaels F, Meyers WM: Les infections cutanées à Mycobacterium ulcerans: Ulcères de Buruli. Med Trop 1995, 55: 363-373.
[2] Connor DH, Meyers WM, Krieg RE. 1976 Infection by Mycobacterium ulcerans. In Pathology of Tropical and Extraordinary Diseases. Edited by: Binford CH, Connor DH. Washington, DC: Armed Forces Institute of Pathology 1976: 1: 226.
[3] Duker A. A: Spatial Analysis of Factors Implicated in Mycobacterium ulcerans Infection In Ghana, International Institute for Geoinformation Science & Earth Observation, Enschede, The Netherlands 2005, ISBN: 90-8504- 243-7.
[4] Guédénon A, Zinsou C, Josse R, Andele K, Pritze S, Portaels F, Meyers WM: Traditional treatment of Buruli ulcer in Benin. Arch. Dermatol 1995, 131: 741-742.
[5] Van der Werf TS, van der Graaf WTA, Groothuis DG, Knell AJ: Mycobacterium ulcerans infection in Ashanti Region, Ghana. Trans R Soc Trop Med Hyg 1989, 83: 410-413.
[6] Asiedu K, Etuaful S: Socio-economic Implications of Buruli Ulcer in Ghana: a Three-Year Review. Am J Trop Med Hyg 1998, 59 (6): 1015- 1022.
[7] WHO: World Health Organisation targets untreatable ulcer: report from the first international conference on Buruli ulcer Control and Research. Inter Press Service. Yamoussoukro. Ivory Coast; 1998.
[8] Portaels F: Epidemiology of mycobacterial diseases. Clinics Dermatol 1995, 13: 207-222.
[9] Portaels F: Historical overview of Buruli ulcer. International Conference on Buruli ulcer Control and Research, Yamoussokro, Côte d’Ivoire; 6-8 July, 1998.
[10] Josse R, Guédénon A, Aguiar J, Anagonou S, Zinsou C, Foundohou J, Touze J–E: L’ulcère de Buruli, une pathologie peu connue au Bénin (a propos de 227 cas). Bull Soc Pathol Exot 1994, 87: 170-175.
[11] Johnson PDR, Veitch MGK, Leslie DE, Flood PE, Hayman JA: The emergence of Mycobacterium ulcerans infection near Melbourne. MJA 1996, 164: 76-78.
[12] Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne PA, Meyers WM: Insects in the transmission of Mycobacterium ulcerans infection. The Lancet 1999, 353: 986.
[13] Marsollier L, Robert R, Aubry J, Saint Andre JP, Kouakou H, Legras P, Manceau AL, Mahaza C, Carbonnelle B: Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 2002, 68: 4623- 4628.
[14] Portaels F, Chemlal K, Elsen P, Johnson JA, Hayman J, Hibble R, Kirkwood R, Meyers WM: Mycobacterium ulcerans in wild animals. Rev sci tech 2001, 20 (1): 252-264. ISSN: 2367-8941 156 Volume 2, 2017
[15] Bencko V: Health aspects of burning coal with high arsenic content: the Central Slovakia experience. In ARSENIC- Exposure and Health Efects Edited by: Abernathy CO, Calderon RL, Chappell WR. Chapman and Hall, London; 1997: 84-91.
[16] Asiedu K, Meyers W, Agbenorku P. 2000 Clinical features and treatment. In BURULI ULCER: Mycobacterium ulcerans infection Edited by: Asiedu K, Scherpbier R, Raviglione M. World Health Organisation, Global Buruli Ulcer Initiative; 2000:37-38.
[17] Chowdhury UK, Biswas BK, Dhar RK, Samanta G, Mandal BK, Chowdhury TR, Chakraborti D, Kabir S, Roy S: Groundwater arsenic contamination and suffering of people in Bangladesh. In Arsenic Exposure and Health Effects Edited by: Chappell WR, Abenarthy CO, Calderon RL. Elsevier Science B. V., Amsterdam; 1999: 165-182.
[18] Gebel, T. 2000. Confounding variables in the environmental toxicology of arsenic. Toxicology 144, 155-162.
[19] Pradinaud R, Basset A, Grosshaus E: Vingt cas de mycobactérioses cutanées en Guyane Franςaise. Castellania 1974, 2: 273-274.
[20] Pradinaud R: Mycobactérioses cutanées atypiques. Encycl Méd Chir Dermatol 1980, 12510: B 10-2.
[21] Cebrián ME, Albores MA, GarciaVargas G, Del Razo LM, OstroskyWegman P: Chronic arsenic poisoning in humans. In Arsenic in the Environment, Part II: Human Health Ecosystem Effects. Edited by: Nriago JO. John Wiley, New York; 1994: 93- 107.
[22] Sun GF, Dai GJ, Li FJ, Yamauchi H, Yoshida T, Aikawa H: The present situation of chronic arsenism and research in China. In Arsenic Exposure and Health Effects. Edited by: Chappell WR, Abernathy CO, Calderon RL. Elsevier Science Amsterdam; 1999: 123-125.
[23] Zaldivar R, Guillier A: Environmental and clinical investigations on the endemic chronic arsenic poisoning in infants and children. Zbl Bakt Hyg I Abt Orig B 1977, 165: 226-234.
[24] Meyers W, Hayman J: Pathology. In BURULI ULCER: Mycobacterium ulcerans infection. Edited by: Asiedu K, Scherpbier R, Raviglione M, World Health Organisation, Global Buruli Ulcer Initiative; 2000: 35-36.
[25] Guha Mazumber DN, Das Gupta J, Santra A, Pal A, Ghose A, Sarkar S, Chattopadhaya N, Chakraborti D: Non-cancer effects of chronic arsenicosis with special reference to liver damage. In ARSENIC – Exposure and Health Effects. Edited by: Abernathy CO, Calderon RL, Chappell WR. Chapman and Hall, London; 1997: 112-123.
[26] Small PLC, George K: Toxin. In BURULI ULCER: Mycobacterium ulcerans infection. Edited by: Asiedu K, Scherpbier R, Raviglione M. World Health Organisation, Global Buruli Ulcer Initiative; 2000: 31-34.
[27] Rosenberg HG: Systemic arterial disease and chronic arsenicism in infants. Arch Pathol 1974, 97: 360- 365.
[28] Van der Werf TS, van der Graaf WTA, Tappero JW, Asiedu K: Mycobacterium ulcerans infection. The Lancet 1999, 354: 1013-1018.
[29] Gyasi SF, Awuah E, Larbi JA, Koffuor GA, Osei O-A: Clinical hematological and hispathological responses to arsenic toxicity in ICR mice using arsenic levels synonymous to Buruli ulcer endemic communities in the Amansie West District of ISSN: 2367-8941 157 Volume 2, 2017 Ghana. European J Exp Biol 2012, 2 (3): 683-689.
[30] Adriano, DC: Trace Elements in Terrestrial Environments: Biogeochemistry, Bioavailability and Risk of Metals. Springe Verlag; 2001: 867.
[31] Bettley FR, O’Shea JA: The absorption of arsenic and its relation to carcinoma. Br J Dermatol 1975, 92: 563-568.
[32] Henke K: Arsenic: Environmental Chemistry, Health Threats and Waste Treatment, John Wiley & Sons 2009, ISBN: 9780470741122.
[33] Smith AH, Lingas EO, Rahman M: Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull WHO 2000, 78: 1093-1103.
[34] Tseng WP: Effects and dose-response relationships of skin cancer and Blackfoot disease with arsenic. Environ Health Perspect 1977, 19: 109-119.
[35] Pershagen G. 1986 Sources of exposure and biological effects of arsenic. In Environmental Carcinogens. Selected Methods of Analysis, vol. 8 – Some Metals: As, Be, Cd, Cr, Ni, Pb, Se, Zn. Edited by: O’Neill IK, Schuller P, Fishbein L. IARC Publication No. 71, Chap. 3, International Agency for Research on Cancer, Lyon, France; 1986: 45-61.
[36] Chen CJ, Hsueh YM, Tseng MP, Lin YC, Hsu LI, Chou WL, Chiou HY, Wang IH, Chou YL, Tseng CH, Liou SH: Individual susceptibility to arseniasis. In Arsenic Exposure and Health Effects IV. Edited by: Chappell WR, Abernathy CO, Calderon RL. Elsevier Science, Amsterdam; 2001: 135-143.
[37] Valentine Jl, Reisbord LS, Kang HK, Schluchter MD: Arsenic effects on population health histories. In Trace elements in man and animals – TEMA 5: Proceedings of the Fifth International Symposium on Trace Elements in Man and Animals.Mills CF, Bremner I, Chesters JK. Slough, UK: Commonwealth Agricultural Bureaux; 1985: 289-294.
[38] Guha Mazumber DN, Chakraborty AK, Ghose A, Gupta JD, Chakraborty DP, Dey SB, Chattopadhyay N: Chronic arsenic toxicity from drinking tubewell water in rural West Bengal. Bull WHO 1988, 66 (4): 499- 506.
[39] Guha Mazumber DN, Haque R, Ghosh N, De BK, Santra A, Chakraborty D, Smith AH: Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int J Epidemiol 1998, 27: 871-877.
[40] Beckett WS, Moore JL, Keogh JP, Bleecker ML: Acute encephalopathy due to occupational exposure to arsenic. Br J Ind Med 1986, 43: 66-67.
[41] Ide CW, Bullough GR: Arsenic and old glass. J Soc Occup Med 1988, 38: 85-88.
[42] Morton WE, Caron GA: Encephalopathy: an uncommon manifestation of workplace arsenic poisoning? Am J Ind Med 1989, 15: 1- 5.
[43] Buchet JP, Lauwerys R: Evaluation of exposure to inorganic arsenic in man. In: Analytical techniques for heavy metals in biological fluids. Edited by: Fachetti S. Elsevier, Amsterdam; 1983: 75-90.
[44] Leonard A: Arsenic. In Metals and their compounds in the environment. Edited by: Meriam E. VCH, Weinheim; 1991: 751-772.
[45] Brown, H. S., Bishop, D R. and Rowan, C. A. The role of skin absorption as a route of exposure for volatile organic compounds (VOCs) ISSN: 2367-8941 158 Volume 2, 2017 in drinking water. American Journal of Public Health May 1984: Vol. 74, No. 5, pp. 479-484.
[46] Dutkiewicz, T. (1977). Experimental studies on arsenic absorption routes in rats. Environ. Health Perspect. 19, 173- 177.
[47] Wester R.C., Maibach H.I., Sedik L., Melendres J., Wade M. In vivo and in vitro percutaneous absorption and skin decontamination of arsenic from water and soil. Fundam. appl. Toxicol. 1993;20:336–340.
[48] Rahman M.S., Hall L.L., Hughes M.F. In vitro percutaneous absorption of sodium arsenate in B6C3F1 mice. Toxicol. in Vitro. 1994;8:441– 448.
[49] Knobeloch, L. 2002. Health effects of arsenic-contaminated drinking water. Final
[50] Farmer JG, Johnson LR: Assessment of occupational exposure to inorganic arsenic based on urinary concentrations and speciation of arsenic. Br J Ind Med 1990, 42: 342- 348.
[51] ATSDR (Agency for Toxic Substances and Disease Registry), 1990. ATSDR Case Studies in Environmental Medicine. Agency for Toxic Substances and Disease.
[52] Ishinishi H, Tsuchiya K, Vahter M, Fowler BA: Arsenic. In Handbook on the Toxicology of Metals, 2nd ed., Chap 3. Edited by: Friberg L, Nordberg GF, Vouk V. Elsevier Science Publishers; 1986: 43-83.
[53] Kitchin KT: Recent advances in arsenic carcinogenesis: Modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 2001, 172: 249-261.
[54] Abernathy CO, Lui YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M: Arsenic. Health effects, mechanisms of actions and research issues. Environ Health Perspect 1999, 107: 593-597.
[55] NRC: Arsenic in drinking water. National Research Council. Washington, D. C., National Academy Press; 1999.
[56] Harrison MT, McCoy KL: Immunosuppression by arsenic: a comparison of cathepsin L inhbition and apoptosis. Int Immunopharmacol 2001, 1: 647-656.
[57] Vega L, Ostrosky-Wegman P, Fortoul TI, Diaz C, Madrid V, Saavedra R: Sodium arsenite reduces proliferation of human activated T- cells by inhibition of the secretion of interleukin-2. Immunopharmacol. Immunotoxicol 1999, 21: 203-220.
[58] Lantz RC, Parliman G, Chen GJ, Carter DE: Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble As (III) and As (V). Environ Res 1994, 67 (2): 183-195.
[59] Ahmad S, Kitchin KT, Cullen W R: Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch Biochem Biophys 2000, 382 (2): 195-202.
[60] Bullen, JJ: The significance of iron in infection. Rev Infect Dis 1981, 3: 1127-1138.
[61] Sugarman B: Effects of heavy metals on bacterial adherence. J Med Microbiol 1980, 13: 351-354.
[62] Frenkel K, Rossman TG, Yang CF: Cafeic acid phenethyl ester (CAPE) prevents arsenic-mediated transformation of human cells and down-regulation of inflammatory cytokines. Paper presented at the International Symposium on Predictive Oncology and Intervention Strategies; Paris, France; February 9- 12, 2002. ISSN: 2367-8941 159 Volume 2, 2017
[63] Golden MHN, Harland PSEG, Golden BE, Jackson AA: Zinc and immunocompetence in proteinenergy malnutrition. The Lancet 1978, 311 (8076): 1226-1228.
[64] Cunningham-Rundles S, Lin DH: Nutrition and the immune system of the gut. Nutrition 1998, 14: 573-579.
[65] Lewis TA, Hartmann CB, McCoy KL: Gallium arsenide differentially affects processing of phagolysosomal targeted antigen by macrophages. J Leucoc Biol 1998a, 63: 321-330.
[66] Lewis TA, Hartmann CB, McCoy KL: Gallium arsenide modulates proteolytic cathepsin activities and antigen processing by macrophages. J Immunol 1998b, 161: 2151-2157.
[67] Sikorski, E.E., McCay, J.A., White, K.L., Bradley, S.G. and Munson, A.E., 1989. Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice. Fundamental and Applied Toxicology, 13(4), pp.843-858.
[68] Lewis TA, Munson AE, McCoy KL: Gallium arsenide selectively suppresses antigen processing by splenic macrophages for CD4+ T cell activation. J Pharmacol Exp Ther 1996, 278: 1244-1251.
[69] Rosales-Castillo JA, AcostaSaavedra LC, Torres R, OchoaFierro J, Borja-Aburto VH, LopezCarrilo L, Garcia-Vargas GG, Gurola GB, Cebrian ME, Calderón-Aranda ES: Arsenic exposure and human papillomavirus response in nonmelanoma skin cancer Mexican patients: a pilot study. Int Arch Occup Environ Health 2004, 77 (6): 418- 423.
[70] Gerdsen R, Stockfleth E, Uerlich M, Fartasch M, Steen KH, Bieber T: Papular palmoplantar hyperkeratosis following chronic medical exposure to arsenic: human papillomavirus as a co-factor in the pathogenesis of arsenical keratosis? Acta Derm Venereol 2000, 80: 292-293.
[71] Karcher, S., Cáceres, L., Jekel, M., Contreras, R. 1999. Arsenic removal from water supplies in Northern Chile using ferric chloride coagulation. J Chart Inst Water Environ Manag 13, 164-169.
[72] Aranyi, C., Bradof, J. N., O’Shea, W. J., Graham, J. A., Miller, F. J. 1985. Effects of arsenic trioxide inhalation exposure on preliminary antibacterial defenses in mice. Arch Environ Health 41, 171-177.
[73] Stienstra Y, van der Graaf WTA, te Meerman GJ, The TH, de Leij F, van der Werf TS: Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health 2001, 6: 554-562.
[74] Gooding TM, Johnson PDR, Campbell DE, Hayman JA, Hartland EL, Kemp AS, Robins-Browne RM: Immune response to infection with Mycobacterium ulcerans. Infect Immun 2001, 69 (3): 1704-1707.
[75] Gooding TM, Johnson PDR, Smith M, Kemp AS, Robins-Browne RM: Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun 2002, 70 (10): 5562-5567.
[76] Sathe SS, Gascone P, Lo W, Pinto R, Reichman LB: Severe anaemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome. Am Rev Respir Dis 1990, 142: 1306-1312.
[77] Bogner, J. R., Gathof, B., Heinrich, B., Matuschke, A., Backer, U., Goebel, F. D. 1990. Erythrocyte antibodies in AIDS are associated with mycobacteriosis and hypergammaglobulinemia. Klin Wochenschr 68, 1050-1053.
[78] Gascon P, Sathe SS, Rameshwar P: Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med 1993, 94: 41-48.
[79] Armstrong CW, Stroube RB, Rubio T, Siudyla EA, Miller GB: Outbreak of fatal arsenic poisoning caused by contaminated drinking water. Arch. Environ. Health 1984, 39 (4): 276- 279.
[80] Goldsmith S, From AHL: Arsenicinduced atypical ventricular tachycardia. N Engl Med 1986, 303: 1096-1097.
[81] Franzblau, A., and Lilis, R. (1989). Acute arsenic intoxication from environmental arsenic exposure. Archives of Environmental Health, 44(6), 385-390.
[82] Wagner, S.L, J.S. Maliner, W.E. Morton, and R.S. Braman. 1979. Skin cancer and arsenical intoxication from well water. Arch. Dermatol. 115:1205-1207.
[83] Cullen NM, Wolf LR, St Clair D: Pediatric arsenic ingestion. Am J Emerg Med 1995, 13 (4): 432-435.
[84] Concha G, Vogler G, Lexcano D, Nermell B, Vahter M: Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 1998, 44: 185-190.
[85] Lugo G, Cassady G, Palmissano P. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child. 1969;117:328–330.
[86] Anderson HA, Wolff MS: Environmental contaminants in human milk. J Exp Anal Environ Epidemiol 2000, 10: 755-760.
[87] Harding ER: Arsenic contamination of garden soils and housedusts in West Cornwall. Bsc. Dissertation, Imperial College of Science, Technology and Medicine, London; 1993.
[88] Thornton I, Farago M: The geochemistry of arsenic. In Arsenic Exposure and Health Effects. Edited by: Abernathy CO, Calderon RL, Chappell WR. Chapman and Hall, London; 1997: 2-15.
[89] Thornton I: Sources and pathways of arsenic in the geochemical environment: health implications. In Environ Geochem Health with special reference to developing countries. Edited by: Appleton JD, Fuge R, McCall GJH. Geological Society Special Publication no. 113, Geological Society, London; 1996: 153-161.
[90] Simkin T, Siebert L: Volcanoes of the World: Geoscience Press, Tucson, Arizona; 1994: 349 pp.
[91] Taylor GAM: The 1951 eruption of Mount Lamington, Papua: Commonwealth of Australia, Bureau of Mineral Resources, Geology and Geophysics; 1957: Bulletin No. 38, 119 pp.
[92] Radford AJ: Mycobacterium ulcerans infection in Papua New Guinea. PNG Med J 1974, 17: 145-149.
[93] Nriagu, J. O. 1979. Global inventory of natural and anthropogenic emissions of trace metals to the atmosphere. Nature, 279, 409-411.
[94] Nriagu JO: A global assessment of natural sources of atmospheric trace metals. Nature 1989, 338: 47-49.
[95] Lantzy RJ, MacKenzie FT: Atmospheric trace metals: global cycles and assessment of man’s impact. Geochim Cosmochim Acta 1979, 43: 511-525. ISSN: 2367-8941 161 Volume 2, 2017
[96] Nriagu JO, Pacyna JM: Quantitative assessment of worldwide contamination of air, water and soils by trace metals. Nature 1988, 333: 134-139.
[97] Signorelli S: Distribuzione di arsenico nei fluidi di aree di vulcanismo attivo. Tesi di Laurea, Università di Firenze; 1993 (Italian).
[98] Smedley PL, Kinniburgh DG: A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem 2002, 17: 517- 568.
[99] Nicolli HB, Suriano JM, Peral MAG, Ferpozzi LH, Baleani OA: Groundwater contamination with arsenic and other trace elements in an area of the Pampa, province of Córdoba, Argentina. In Water-Rock Interaction 2001, vol 2. Edited by: Cidu R. Swets & Zeitlinger, Lisse; 1989: 993-996.
[100] Nriagu, J.O., Bhattacharya, P., Mukherjee, A.B., Bundschuh, J., Zevenhoven, R. and Loeppert, R.H., 2007. Arsenic in soil and groundwater: an overview. Trace Metals and other Contaminants in the Environment, 9, pp.3-60.
[101] Boyle RW, Jonasson IR: The geochemistry of arsenic and its use as an indicator element in geochemical prospecting. J Geochem Explor 1973, 2: 251-296.
[102] Smedley PL, Kinniburgh DG: Arsenic in Ground Water and the Environment. British Geological Survey 2005, 11: 263-299.
[103] Bowell, RJ: Supergene gold mineralogy at Ashanti, Ghana: implications for the supergene behaviour of gold. Mineralog Mag 1992, 56; 545-560.
[104] Wright JB, Hastings DA, Jones WB: Geology and Mineral Resources of West Africa. George Allen and Unwin Publishers, London; 1985: 185 pp.
[105] Laverman AM, Switzer Blum J, Schaeffer JK, Philips EJ, Lovley DR, Oremland RS: Growth of strain SES3 with arsenate and other diverse electron acceptors. Appl Environ Microbiol 1995, 61: 3556-3561.
[106] Stolz JF, Ellis DJ, Switzer Blum J, Ahmann D, Oremland RS, Lovley DR: Sulfurospirillum barnesii sp. Nov., Sulfurospirillum arsenophilus sp. Nov., and the Sulfurospirillum clade in the Epsilon Proteobacteria. Int. J. Systematic Bacteriol 1999, 49: 1177-1180.
[107] Hoeft SE, Kulp TR, Stolz JF, Hollibaugh JT, Oremland RS: Dissimilatory arsenate reduction with sulfide as the electron donor: Experiments with Mono Lake water and isolation of strain MLMS-1, a chemoautotrophic arsenate-respirer. Appl Environ Microbiol 2004, 70: 2741-2747.
[108] Santini JM, Sly LI, Schnagl RD, Macy JM: A new chemolithoautotrophic arseniteoxidizing bacterium isolated from a gold mine: Phylogenetic, physiological, and preliminary biochemical studies. Appl Environ Microbiol 2000, 66: 92-97.
[109] KENOR ASA. Annual Report. www.guinor.com/company_documen ts/annual_reports/1995.pdf. Accessed 23/6/2004.
[110] Aguiar J, Steunou C:
[Buruli ulcers in rural areas of Benin: management of 635 cases]. Med Trop 1997, 57: 83- 90.
[111] Amofah, GK: Control and management of Buruli ulcer disease. Ghana Med J 1995, 29: 589-602.
[112] Amofah GK, Sagoe-Moses C, AdjeiAcquah C, Frimpong EH: Epidemiology of Buruli ulcer in ISSN: 2367-8941 162 Volume 2, 2017 Amansie West District, Ghana. Trans Roy Soc Trop Med Hyg 1993, 87: 644- 645.
[113] Marston BJ, Diallo MO, Horsburgh RC, Diomande I, Saki MZ, Kanga M, Patrice G, Lipman HB, Ostroff SM, Good RC: Emergence of Buruli ulcer disease in the Daloa region of Côte d’Ivoire. Am J Med Hyg 1995, 52: 219-224.
[114] Monson MH, Gibson DW, Connor DH, Kappes R, Hienz H: Mycobacterium ulcerans in Liberia: a clinicopathological study of 6 patients with Buruli ulcer. Acta Trop 1984, 41: 165-172.
[115] Grosset J, Kanga JM, Portaels F, Guédénon A, Tignokpa N, Scherpbier R, Asiedu K: Country assessment report (Annex 5). In. BURULI ULCER: Mycobacterium ulcerans infection. Edited by: Asiedu K, Scherpbier R, Raviglione M. World Health, Organisation, Global Buruli Ulcer Initiative; 2000: 87-92.
[116] Azcue JM, Nriagu JO: Arsenic: historical perspectives. In Arsenic in the environment, Part I: Cycling and characterization. Edited by: Nriagu, JO. John Wiley, New York; 1994: 1- 15.
[117] Buchanan GA: The seasonal abundance and control of light brown apple moth, Epiphyas postvittana (Walker) (Lepidoptera: Tortricidae), on grapevines in Victoria. Aus J Agric Res 1977, 28: 125-132.
[118] Yoon JK, Kim KS: Control of the fruitpiercing moths. Korean J Plant Protect 1977, 16: 127-131.
[119] Davies BE, Jones LHP: Micronutrients and toxic elements. In Russell’s soil conditions and plant growth. Edited by: Wild A. Longman Scientific and Technical, Essex; 1988: 780-814.
[120] Green K, Broome L, Heinze D, Johnston S: Long distance transport of arsenic by migrating Bogon Moth from agricultural lowlands to mountain ecosystem. Vict Natural 2001, 118 (4): 112-116.
[121] Welch AH, Lico MS, Hughes JL: Arsenic in ground water of the Western United States. Ground water 1988, 26 (3): 333-347.
[122] Siegel FR: Environmental Geochemistry of Potentially Toxic Metals. Springer-Verlag, Berlin Heidelberg; 2002: 218pp.
[123] Mantey, S., Amankwah, R.K. and Duker, A. A (2014), Spatial Dependency of Buruli ulcer on Potential Surface Runoff and Potential Maximum Soil Water Retention, International Journal of Research In Medical and Health Sciences pp 01 -15 Vol. 03. No. 5– 2014.
[124] Pearson AL: A retrospective applied case study of environmental and host characteristics of Buruli ulcer patients in the Amansie West District, 1996- 1999. Msc. Thesis, Western Washington University, USA; 2001.
[125] Duker AA, Carranza EJM, Hale M: Spatial relationship between arsenic in drinking water and Mycobacterium ulcerans infection in the Amansie West District, Ghana. Min Mag 2005, 69 (5): 707-717.
[126] Duker A. A, Carranza E, Hale M: Spatial dependency of Buruli ulcer prevalence on arsenic-enriched domains in Amansie West District, Ghana: implications for arsenic mediation in Mycobacterium ulcerans infection, International Journal of Health Geographics 2004, 3:19.
[127] Hayman JA, Huygens HJ: Mycobacterium ulcerans across lake Victoria. Med J Aust 1982, 1: 138. ISSN: 2367-8941 163 Volume 2, 2017
[128] Aggett J, Kriegman MR: The extent of formation of arsenic (III) in sediment interstitial waters and its release to hypolimnetic waters in Lake Ohakuri. Water Res 1988, 22 407-411.
[129] BGS. 2000. Water Quality Fact Sheet: Arsenic. British Geological Survey, Keyworth.
[130] Tole MP: The potential of geothermal systems in Kenya for balneological use. Environ Geochem Health 2002, 24 (2): 103-110.
[131] Barker DJP: Buruli disease in a district of Uganda. J Trop Med Hyg 1971, 74: 260-264.
[132] Nimick, D. A., Moore, J. N., Dalby, C. E., Savka, M. W. 1998. The fate of geothermal arsenic in the Madison and Missouri Rivers, Montana and Wyoming. Water Resour Res34, 3051-3067
[133] McLaren SJ, Kim ND: Evidence for a seasonal fluctuation of arsenic in New Zealand’s longest river and the effect of treatment on concentrations in drinking water. Environ Pollut 1995, 90: 67-73.
[134] Azcue JM, Nriagu JO: Impact of abandoned mine tailings on the arsenic concentrations in Moira Lake, Ontario. J Geochem Explor 1995, 52: 81-89.
[135] Oluwasanmi JO, Solanke TF, Olurin EO, Itayemei SO, Alabi GO, Lucas AO: Mycobacterium ulcerans (Buruli) skin ulceration in Nigeria. Am J Trop Med Hyg 1976, 25: 122- 128
[136] Ziefer A, Connor DH, Gibson DW: Mycobacterium ulcerans infection of two patients in Liberia. Int J Dermatol 1981, 20: 362-367.
[137] Peraudin ML, Herrault A, Desbois JC: Ulcère cutané à Mycobacterium ulcerans (ulcère de Buruli). Annal Pédiat 1980, 27 (10): 687-692.
[138] Mensah-Quainoo EK: A study of the magnitude and determinants of Buruli ulcer disease in the Ga District of Ghana. International Conference on Buruli ulcer Control and Research, Yamoussoukro, Côte d’Ivoire; 6-8 July, 1998.
[139] Armah, AK, Darpaah GA, Carboo D: Heavy metal levels and physical parameters of drainage ways and wells in three mining areas in Ghana. J Ghana Sci Assoc 1998, 1 (1): 113- 117.
[140] Beining BA, Otte ML: Retention of metals originating from an abandoned lead-zinc mine by a wetland at Glendalough, Co. Wicklow. Biology and Environment. Proceedings of the Royal Irish Academy 1996, 96B(2): 117-126.
[141] Miller JR: The role of fluvial geomorphic process in the dispersal of heavy metals from mine sites. J Geochem Explor 1997, 58 (2-3): 101- 118.
[142] Hess RE, Blanchar RW: Dissolution of arsenic from waterlogged and aerated soil. Soil Sci Soc Am J 1977, 41: 861-865.
[143] McGeehan SL, Naylor DV: Sorption and redox transformation of arsenite and arsenate in two flooded soils. Soil Sci Soc Am J 1994, 58: 337-342.
[144] Masscheleyn PH, DeLaune RD, Patrick WH: Effect of redox potential and pH on arsenic speciation and solubility in a contaminated soil. Environ Sci Technol 1991, 25: 1414- 1419.
[145] Bickford G, Toll J, Hansen J, Bake E, Keesen R: Aquatic ecological and human health risk assessment of chemicals in wet weather discharges in Sydney region, New South Wales, ISSN: 2367-8941 164 Volume 2, 2017 Australia. Mar Pollut Bull 1999, 39 (1-12): 335-345.
[146] Stoughton JA, Marcus WA: Persistent impacts of trace metals from mining on floodplain grass communities along soda butte creek, yellow stone national park. Environ Manag 2000, 25 (3): 305-320.
[147] Meyers, W. M., Tignokpa, N., Priuli, G. B., Portaels, F. 1996. Mycobacterium ulcerans infection (Buruli ulcer): first reported patient in Togo. Br J Dermatol 134, 1116-1121.
[148] Barker DJP: Mycobacterial skin ulcers. Br J Dermatol 1974, 91: 473- 474.
[149] Hayman J: Mycobacterium ulcerans infection in Victoria: celebration of a golden jubilee? Aust J Dermatol 1987, 28: 99-105.
[150] Ravisse P: L’ulcère cutané à Mycobacterium ulcerans au Cameroun. 1. Etude clinique épidemiologique et histologique. Bull Soc Pathol Exot 1977, 70: 109-124.
[151] Andreae, MO: Distribution and speciation of arsenic in natural waters and some marine algae. Deep Sea Res 1978, 25: 391-402.
[152] Andreae, M. O. 1979. Arsenic speciation in seawater and interstitial waters: the biological, chemical interactions on the chemistry of a trace element. Limnol Oceanol 24, 440-452.
[153] Savage KS, Bird DK, Ashley RP: Legacy of the California Gold Rush: Environmental geochemistry of arsenic in southern Mother Lode Gold District. Int Geol Rev 2000, 42 (5): 385-415.
[154] Rodríguez R, Ramos JA, Armienta A: Groundwater arsenic variations: the role of local geology and rainfall. Appl Geochem 2004, 19: 245-250.
[155] Akai J, Izumi K, Fukuhara H, Masuda H, Nakano S, Yoshimura T, Ohfuji H, Anawar HM, Akai K: Mineralogical and geomicrobiological investigations on groundwater arsenic enrichment in Bangladesh. Applied Geochem 2004, 19: 215-230.
[156] Maest AS, Pasilis SP, Miller LG, Nordstrom DK: Redox geochemistry of arsenic and iron in Mono Lake, California, USA. In Proc. 7th Int Symp Water-Rock Interaction. Edited by: Kharaka YK, Maest AS. A. A. Balkema, Rotterdam; 1992: 507-511.
[157] Sarkodie PH, Nyamah D, AmonooNeizer EH: Speciation of arsenic in some biological samples from Obuasi and its surrounding villages. National Symposium Proceedings – The Mining Industry and the Environment, UST, Kumasi; April 14-15, 1997: 146-154.
[158] Ostrosky-Wegman P, Gonseblatt ME, Montero R, Vega L, Barba H, Espinosa J, Palao A, Cortinas C, Garcia-Vargas G, Del Razo LM, Cebrian M: Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat Res 1991, 250: 477-482.
[159] Hayman J: Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol 1991, 20: 1093-1098.
[160] Meyers WM: Mycobacterial infections of the skin. In Tropical Dermatology. Edited by: Seifert G. Heidelberg: Springer-Verlag, ch. 9; 1994.
[161] Debacker M, Aguiar J, Stenou C, Zinsou C, Meyer WM, Scott JT, Dramaix M, Portaels F: Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004: 9 (12): 1297-1304.
|
PDF
